Back to Search
Start Over
Patient preference for second- and third-line therapies in type 2 diabetes: a prespecified secondary endpoint of the TriMaster study
- Source :
- Nature Medicine. 29:384-391
- Publication Year :
- 2022
- Publisher :
- Springer Science and Business Media LLC, 2022.
- Subjects :
- General Medicine
General Biochemistry, Genetics and Molecular Biology
Subjects
Details
- ISSN :
- 1546170X and 10788956
- Volume :
- 29
- Database :
- OpenAIRE
- Journal :
- Nature Medicine
- Accession number :
- edsair.doi...........76263583b3fea82556f87961f9b49dab
- Full Text :
- https://doi.org/10.1038/s41591-022-02121-6